The University of Texas MD Anderson Cancer Center and MD … · 2020-06-15 · • Understand molecular biology and immunology of brain metastases to utilize the most effective systemic

OC

TO

BER

12-

13, 2

019

The University of Texas MD Anderson Cancer Center and MD Anderson Cancer Network Symposium

Clinical Program:A MULTIDISCIPLINARY APPROACH TO INDIVIDUALIZED PATIENT CARE

Nursing Excellence: NAVIGATING THE CHANGING LANDSCAPE OF ONCOLOGY NURSING

Marriot t Marquis Houston1777 Walker StreetHouston, Texas

Program ChairJeffrey E. Lee, MD Professor and Chair Surgical Oncology

THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND MD ANDERSON CANCER NETWORK SYMPOSIUM


Nursing Excellence: NAVIGATING THE CHANGING LANDSCAPE OF ONCOLOGY NURSING

OCTOBER 12-13, 2019

SATURDAY, OCTOBER 12 5:30 PM

Katy Rezvani, MD, PhD Professor

Stem Cell Transplantation

SATURDAY, OCTOBER 12 6:00 PM

Scott Kopetz, MD, PhD Associate Professor

Gastrointestinal Medical Oncology

SUNDAY, OCTOBER 13 7:00 AM

Jennifer L. McQuade, MD Assistant Professor

Melanoma Medical Oncology

SUNDAY, OCTOBER 13 12:35 PM

Funda Meric-Bernstam, MD Professor and Chair

Investigational Cancer Therapeutics

CAR NK Cell Therapy The Promise of Liquid Biopsy in Cancer Care

The Role of the Microbiome in the Response to Immunotherapy

Emerging Actionable Genomic Alterations

Symposium Highlights


Goal

A multidisciplinary approach in the treatment of patients diagnosed with

cancer has been the key for delivering high quality care. A tsunami created by

rapidly expanding knowledge in tumor molecular biology and immunology,

moreover, new molecular approaches have enabled the development

of therapeutics that target specific oncogenic mutations and immune

checkpoints. This constant evolution has maintained a dynamic relationship

with the disciplines - surgery, radiation therapy and medical oncology-

modulating the approach to provide individualized patient care. The advances

and emerging data is much needed in community settings in order to deliver

quality care and to improve patient outcomes.

Educational Objectives

After attending the symposium, participants should be able to

• Provide a multidisciplinary approach

in the management of melanoma

patients (Knowledge, Competence);

• Implement new practice changes

in breast cancer treatment involving

fields that will positively influence

patient outcomes in terms of

quality of life and survival

(Knowledge, Competence,

Performance, Patient Outcomes);

• Select the best strategies in the

surgical management of gynecologic

malignancies to enhance post-op

recovery, reduce morbidity and

lead to better quality of life and

outcomes (Knowledge, Competence,

Performance, Patient Outcomes);

• Select the most appropriate

gastrointestinal treatment option/

modality (Knowledge, Competence);

• Utilize new management methods for

genitourinary cancers (Knowledge,

Competence, Performance);

• Utilize a multidisciplinary approach

and targeted treatment strategies

in the management of thyroid

cancer (Knowledge, Competence,

Performance);

• Understand molecular biology and

immunology of brain metastases to

utilize the most effective systemic

treatments, targeted therapies,

checkpoint inhibitors, neurosurgical

procedures and radiation (Knowledge);

• Assess treatment guidelines, goals,

monitoring tools and treatment

approaches in care of hematologic

malignancies (Knowledge,

Competence);

• Select patients and identify the

appropriate class of agents in the

treatment of metastatic NSCLC and

select local modalities of treatment

for oligometastatic disease

(Knowledge, Competence);

• Appreciate the role of salvage surgery

in the management of esophageal

cancer (Knowledge);

• Appreciate the future status of CAR

NK Cells, liquid biopsies, microbiome

and emerging actionable mutations.

(Knowledge).

Target Audience

This symposium will be beneficial to

Medical Oncologists, Surgical Oncologists,

Radiation Oncologists, General Surgeons,

Internists, Researchers, Physician

Assistants, Oncology Nurses and

Advanced Practice Nurses.

Educational Methods

Lecture/Didactic – Case Study – Audience

Response System- Question/Answer

Sessions – Panel Discussion

Evaluation

A course evaluation survey will provide

participants with the opportunity to

comment on the value of the program

content to their practice decisions,

performance improvement activities,

or possible impact on patient health

status. Participants will also have

the opportunity to comment on any

perceived commercial bias in the

presentations as well as to identify future

educational topics.

Accreditation / Credit Designation

The University of Texas MD Anderson

Cancer Center is accredited by the

Accreditation Council for Continuing

Medical Education (ACCME) to provide

continuing medical education for

physicians.

The University of Texas MD Anderson

Cancer Center designates this live activity

for a maximum of 17.00 AMA PRA Category

1 CreditsTM. Physicians should claim only

the credit commensurate with the extent of

their participation in the activity.

Ethics Credits

The presentation, Increasing HPV Vaccine

Confidence and Understanding HPV

Vaccine Efficacy and Indications, has been

designated by The University of Texas MD

Anderson Cancer Center for a total of .25

AMA PRA Category CreditsTM in medical

ethics and/or professional responsibility.

ABIM Maintenance of Certification

Successful completion of this CME activity,

which includes participation in the evaluation

component, enables the participant to earn up

to 17 Medical Knowledge MOC points in the

American Board of Internal Medicine’s (ABIM)

Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent

to the amount of CME credits claimed for

the activity. It is the CME activity provider’s

responsibility to submit participant completion

information to ACCME for the purpose of

granting ABIM MOC credit.

Participant completion data will be shared

with and transmitted to the ACCME on the

participant’s behalf.

In order to receive MOC points, you must pass

the post-test with a score of 75% or higher.

American Board of Surgery (ABS) MOC Part II Credit

This live activity is approved for AMA

PRA Category 1 CreditsTM and has met

the American Board of Surgery (ABS)

requirements. Successful completion of this

CME activity, which includes participation in

the self-assessment component, enables the

participant to earn self-assessment credits

toward Part 2 of the ABS MOC Program.

In order to receive MOC points, you must pass

the post-test with a score of 75% or higher.

CME Certificates and Attendance Verification Certificates

Certificates awarding AMA PRA Category 1

CreditTM or certificates documenting

attendance will be emailed when an individual

completes the online CME Verification process

after the conference.

Planning Committee

Jeffrey E. Lee, MD (Chair)

Fred Ames, MD

Richard Babaian, MD

Gildy Babiera, MD

Miloslav Beran, MD, PhD

Peter Dempsey, MD

Merrill Kies, MD

Deborah A. Kuban, MD

Benjamin Lichtiger, MD, PhD

Peter McLaughlin, MD

Nicholas Papadopoulos, MD

William Simeone, Jr., MHA

Camerone Spoons, MBA

Richard L. Theriault, DO

Deborah Thomas, MEd

Coni Tierney, CMP

Allison Baring, CMP

| 6:30am Registration and Continental Breakfast

| 7:00 Welcome Jeffery E. Lee, MD

| 7:05 The University of Texas MD Anderson Cancer Center Greeting Peter WT Pisters, MD

Melanoma

Emerging Approaches in the Management of Melanoma

Session Chair: Hussein A. Tawbi, MD, PhD

| 7:10 Session Introduction Hussein A. Tawbi, MD, PhD

| 7:20 Neoadjuvant Targeted and Checkpoint Therapy of Melanoma Rodabe N. Amaria, MD

| 7:40 Identifying and Overcoming Resistance to Melanoma Systemic Therapy Michael A. Davies, MD, PhD

| 8:00 Personalized Melanoma Surgery in the Modern Era: What are the Roles of SLNB and LND? Jeffrey E. Gershenwald, MD

| 8:20 Cases Moderator: Emily Z. Keung, MD

| 8:50 Break

Breast

Individualizing Multidisciplinary Breast Cancer Care

Session Chair: Henry M. Kuerer, MD, PhD

| 9:00 Session Introduction Henry M. Kuerer, MD, PhD

Agenda

Saturday, October 12, 2019

Clinical Program: A Multidisciplinary Approach to Individualized Patient Care

| 9:10 Integrating Breast Reconstructive Surgery when Post-Mastectomy Radiotherapy is Indicated Mark V. Schaverien, MD

| 9:30 Updates on PARP Inhibitors and Immunotherapy for Breast Cancer Bora Lim, MD

| 9:50 Targeted Axillary Dissection (TAD) and Surgical Management of the Axilla after Neoadjuvant Therapy Abigail S. Caudle, MD

| 10:10 Advances in the Management of HER-2 Positive Breast Cancer Vicente Valero, MD

| 10:30 Cases Moderator: Rosa F. Hwang, MD

| 11:00 Lunch (provided)

Gynecologic Oncology

Innovations and Controversies in Gynecologic Oncology

Session Chair: Amir A. Jazaeri, MD

| 11:15 Session Introduction and Incorporation of Immunotherapy in the Treatment of Gynecologic Cancers Amir A. Jazaeri, MD

| 11:35 Controversies and Outcomes in Minimally Invasive Surgery in Gynecologic Oncology Jose A. Rauh-Hain, MD

| 11:55 Integrating SLN Biopsy Into the Management of Patients with Endometrial Cancer Michael M. Frumovitz, MD

| 12:15 pm Increasing HPV Vaccine Confidence and Understanding HPV Vaccine Efficacy and Indications* Lois M. Ramondetta, MD

| 12:35 Cases Moderator: Larissa A. Meyer, MD

| 12:55 Break

Gastrointestinal Tumors

Management of Gastrointestinal Cancer in 2019: Personalizing Care with Targets, Strategies and Sequencing

Session Chair: Matthew H. G. Katz, MD

| 1:05 Session Introduction Matthew H. G. Katz, MD

| 1:15 Advances in Targeted Therapy for Neuroendocrine Tumors Daniel M. Halperin, MD

| 1:35 Role of Immunotherapy for Gastrointestinal Cancers Michael J. Overman, MD

| 1:55 Progress in Adjuvant and Neoadjuvant Treatment of Pancreatic Cancer Ching-Wei D. Tzeng, MD

| 2:15 Cases Moderator: Naruhiko Ikoma, MD

| 2:45 Break

Genitourinary Tumors

Individualized Management of Patients with GU Malignancies: A 2019 Update

Session Chair: Jose A. Karam, MD

| 2:55 Session Introduction Jose A. Karam, MD

| 3:05 Advances in the Management of Aggressive Variant Prostate Cancer Paul G. Corn, MD, PhD

| 3:25 Choice of First-Line Systemic Therapy in Metastatic Renal Cell Carcinoma Matthew T. Campbell, MD

| 3:45 Management of Patients with Non-Muscle Invasive Bladder Cancer: 2019 and Beyond Neema Navai, MD

| 4:05 Cases Moderator: Brian F. Chapin, MD

| 4:35 pm Adjourn

Evening Keynote Presentations Location: Marriott Marquis Houston

| 5:30 CAR NK Cell Therapy Katy Rezvani, MD, PhD

| 6:00 The Promise of Liquid Biopsy in Cancer Care Scott Kopetz, MD, PhD

| 6:30 Reception

| 7:30 pm Adjourn

*Indicates ethics credit

Sunday, October 13, 2019

| 6:30 am Registration and Continental Breakfast

| 7:00 Keynote Presentation: The Role of the Microbiome in the Response to Immunotherapy Jennifer L. McQuade, MD

Leukemia and Lymphoma

Hematologic Malignancies: 2019 State of the Art Care

Session Chair: Jason R. Westin, MD

| 7:30 Session Introduction Jason R. Westin, MD

| 7:40 Indications for Subcutaneous Cellular Tissue in AML, CML, and MDS in the Era of Targeted Therapy Richard E. Champlin, MD

| 8:00 Novel Treatment Strategies in B-Cell Lymphoma Jason R. Westin, MD

| 8:20 Selecting Treatment for Patients with Multiple Myeloma Robert Z. Orlowski, MD, PhD

| 8:40 Cases Moderator: Fredrick B. Hagemeister, MD

| 9:00 Break

Thoracic Cancers

Update on the Management of Thoracic Malignancies, Lung, Esophagus and metastatic Disease of the Lung

Session Chair: Reza J. Mehran, MD

| 9:10 Session Introduction Reza J. Mehran, MD

| 9:20 Advances in the Treatment of Metastatic NSCLC John V. Heymach, MD, PhD

| 9:40 Location Therapy of Oligo-Metastatic Disease of the Lung: Surgery vs. SABR vs. RFA Reza J. Mehran, MD

| 10:00 Esophageal Cancer: Results and Role of Salvage Surgery Wayne L. Hofstetter, MD

| 10:20 Cases Moderator: Boris Sepesi, MD

| 10:50 Break

Endocrine Cancers

Targeted Treatment Strategies for Thyroid Cancer

Session Chair: Mimi I-Nan Hu, MD

| 11:00 Session Introduction Mimi I-Nan Hu, MD

| 11:10 Multidisciplinary Management to Improve Outcomes of Patients with Anaplastic Thyroid Cancer Maria E. Cabanillas, MD

| 11:30 Integrating Molecular Diagnostics Into the Diagnosis and Management of Thyroid Cancer Sarah B. Fisher, MD

| 11:50 Cases Moderator: Mark E. Zafereo, Jr., MD

| 12:20 pm Lunch (provided)

| 12:35 Keynote Presentation: Emerging Actionable Genomic Alterations Funda Meric-Bernstam, MD

Brain Metastases

Hope, Opportunity and Cure in the Treatment of Brain Metastases

Session Chair: Michael K. Wong, MD, PhD

| 1:05 Session Introduction Michael K. Wong, MD, PhD

| 1:15 Multidisciplinary Management of Melanoma Brain Metastases Isabella C. Glitza Oliva, MD, PhD

| 1:35 Stereotactic Radiosurgery vs Surgery for Brain Metastases Jeffrey S. Weinberg, MD

| 1:55 Cases Moderator: Michael K. Wong, MD, PhD

| 2:25 Closing Remarks

| 2:30 pm Adjourn

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone

who is in a position to control the content of an educational activity must disclose all relevant

financial relationships with any commercial interest that could potentially affect the information

presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational

use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific

disclosure will be made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your

educational experience. MD Anderson may substitute faculty with comparable expertise on rare

occasions necessitated by illness, schedule conflicts, and so forth.

Photographing, audio taping and videotaping are prohibited.

MD Anderson FacultyClinical Program: A Multidisciplinary Approach to Individualized Patient Care

Rodabe N. Amaria, MDAssistant Professor

Melanoma Medical

Oncology

Maria E. Cabanillas, MDAssociate Professor

Endocrine Neoplasia and

Hormonal Disorders

Matthew T. Campbell, MDAssistant Professor

Genitourinary Medical

Oncology

Abigail S. Caudle, MDAssociate Professor

Breast Surgical Oncology

Richard E. Champlin, MDProfessor and Chair


Brian F. Chapin, MDAssociate Professor

Urology

Paul G. Corn, MD, PhDAssociate Professor


Oncology

Michael A. Davies, MD, PhDProfessor and Chair

Melanoma Medical

Oncology

Sarah B. Fisher, MDAssistant Professor

Surgical Oncology

Michael M. Frumovitz, MDProfessor

Gynecologic Oncology &

Reproductive Medicine

Jeffrey E. Gershenwald, MDProfessor

Surgical Oncology

Fredrick B. Hagemeister, MDClinical Professor

Lymphoma/Myeloma

Daniel M. Halperin, MDAssistant Professor

Gastrointestinal Medical

Oncology

John V. Heymach, MD, PhDProfessor and Chair

Thoracic/Head and Neck

Medical Oncology

Wayne L. Hofstetter, MDProfessor

Thoracic & Cardiovascular

Surgery

Mimi I-Nan Hu, MDProfessor

Endocrine Neoplasia and

Hormonal Disorders

Rosa F. Hwang, MDProfessor


Naruhiko Ikoma, MD Assistant Professor

Surgical Oncology

Amir A. Jazaeri, MDProfessor



Jose A. Karam, MDAssociate Professor

Urology

Matthew H.G. Katz, MDAssociate Professor

Surgical Oncology

Emily Z. Keung, MDFellow

Surgical Oncology

Henry M. Kuerer, MD, PhDProfessor


Scott Kopetz, MD, PhDAssociate Professor


Oncology

Jeffrey E. Lee, MDProfessor and Chair

Surgical Oncology

Bora Lim, MDAssistant Professor

Breast Medical Oncology

Jennifer L. McQuade, MDAssistant Professor

Melanoma Medical

Oncology

Reza J. Mehran, MDProfessor

Thoracic &

Cardiovascular Surgery

Funda Meric-Bernstam, MDProfessor and Chair

Investigational Cancer

Therapeutics

Larissa A. Meyer, MDProfessor



Neema Navai, MDAssistant Professor


Oncology

Isabella Glitza Oliva, MD, PhDAssistant Professor

Melanoma Medical

Oncology

Robert Z. Orlowski, MD, PhDProfessor

Lymphoma / Myeloma

Michael J. Overman, MDProfessor

Gastrointestinal Medical

Oncology

Peter WT Pisters, MDPresident

President’s Office

Lois M. Ramondetta, MDProfessor

Gynecologic Oncology and


Jose A. Rauh-Hain, MDAssistant Professor



Katy Rezvani, MD, PhDProfessor


Mark V. Schaverien, MDAssistant Professor

Plastic Surgery

Boris Sepesi, MDAssistant Professor

Thoracic Surgery

Hussein A. Tawbi, MD, PhDAssociate Professor

Melanoma Medical

Oncology

Ching-Wei D. Tzeng, MDAssistant Professor

Surgical Oncology

Vicente Valero, MDProfessor


Jeffrey S. Weinberg, MDProfessor

Neurosurgery

Jason R. Westin, MDAssistant Professor

Lymphoma/Myeloma

Michael K. Wong, MD, PhDProfessor

Melanoma Medical

Oncology

Mark E. Zafereo, Jr., MDAssociate Professor

Head and Neck Surgery

MD Anderson FacultyClinical Program:

A Multidisciplinary Approach to Individualized Patient Care

Nursing Excellence:NAVIGATING THE CHANGING LANDSCAPE OF ONCOLOGY NURSING

Goal

The Nursing Excellence program focuses on current clinical topics across the

continuum of oncology care. After attending this educational activity, the

registered nurse will self-report an understanding of patient navigation practices

in oncology, principles of cancer genetics and appropriate risk assessment,

administration and management of immunotherapy and biosimilars, best practices

in cancer care, ethical considerations in oncology, oncologic emergencies

management, updates in head and neck cancer treatment, and the use of

integrative medicine in oncology. The program will provide an opportunity to

collaborate with MD Anderson Cancer Network and national colleagues and the

potential to earn up to 13.75 nursing contact hours.

The University of Texas MD Anderson Cancer Center is an approved provider with

commendation of continuing nursing education by the Texas Nurses Association

– Approver, an accredited approver with distinction, by the American Nurses

Credentialing Center’s Commission on Accreditation.

Nurses may earn up to 13.75 contact hours for both days.

Planning Committee

Amanda Polk, MS, RN, OCN (Nurse Planner) Laurie Sturdevant, BA, RN, CPHQ, OCN


| 7:15 Welcome Laurie Sturdevant, BA, RN, CPHQ, OCN

| 7:30 Keynote: Navigating the Changing Landscape in Oncology Sharon Gentry, RN, MSN, ONN-CG, AOCN, CBCN

| 8:30 Taking Off the Brakes: Principles of Immunotherapy Virginia Bayer, BSN, RN, OCN

| 9:30 Break

| 10:00 Panel Presentation: Traversing Updates in Immunotherapy Treatment and Management Moderator: Virginia Bayer, BSN, RN, OCN

Panelists:

10:05 CAR T-Cell Therapy Overview Sandra Horowitz, PharmD

10:25 Immunotherapy Overview Jaime Anderson, PharmD

10:45 Immunotherapy Adverse Events Anishia Rawther-Karedath, MS, RN, AGNP-BC

11:05 Q&A Session

| 11:30 Connect Challenge

| 11:45 Lunch (provided)

| 12:45 pm Mapping the Course in Genetics: Basic Genetics and Genetic Counseling Donika Saporito, MS, CGC

| 1:45 Mapping the Course in Genetics: Hereditary Cancer Syndrome Management Banu K. Arun, MD

| 2:45 Break

Agenda

Saturday, October 12, 2019

Nursing Excellence: Navigating The Changing Landscape of Oncology Nursing

| 3:00 Panel Presentation: Piloting Best Practice

Panelists:

3:00 Enhanced Recovery Program: Nursing Considerations Alita A.J. Campbell, MSN, RN, OCN Brittany C. Kruse, DBH, MA, BA

3:15 Safe Handling of Oral Investigational Drugs Doyle Bosque RN, BSN

3:30 Decreasing Unplanned Hospitalizations and ED visits in Gynecologic Oncology Patients Holly Patton, RN, BSN

3:45 CAR T-Cell Toxicity Grading Mobile Application Sherry Adkins, RN, MSN, ANP-C

| 4:00 Ethics in Oncology Care: The Moral Compass Richard L. Theriault, DO, MBA

| 5:00 Closing Remarks/ Evaluations

| 5:15 pm Adjourn

Evening Keynote Presentations Location: Marriott Marquis Houston

| 5:30 CAR NK Cell Therapy Katy Rezvani, MD, PhD

| 6:00 The Promise of Liquid Biopsy in Cancer Care Scott Kopetz, MD, PhD

| 6:30 Reception

| 7:30 pm Adjourn

Sunday, October 13, 2019


| 7:15 Welcome Amanda Polk, MS, RN, OCN

| 7:30 Panel Presentation: Leading the Way in Oncology Nurse Navigation Moderator: Sharon Gentry, RN, MSN, ONN-CG, AOCN, CBCN

Panelists:

7:30 Navigation Program Overview Nicole Luckett, MSN, RN, CBCN

7:45 Lay Navigation Program Holly N. Ho-Chee Dupont Joyce Tokuhara, RN, BSN

8:00 Performance Improvement Acuity Tool for Navigation Colleen Sullivan-Moore, RN, MS

8:15 Focused Thoracic Oncology Navigation Program Ann Werle, RN, BSN, ONN-CG(T)

| 8:30 Forging Ahead: Head and Neck Cancer Overview Katherine Bell, MSN, APRN, AOCNS, ACNS-BC

| 9:30 Break

| 10:00 Oncologic Emergencies Uncovered: Sepsis Danya Garner, MSN, RN-BC, OCN, CCRN

| 11:00 Biosimilars: Taking a New Route Mara Villanueva, PharmD, BCPS Janine S. Douglas, PharmD, BCPS

| Noon Pick Up Box Lunch

| 12:15 pm Lunch and Learn- Drop A Pin: Acupuncture and Integrative Medicine and in Cancer Care Bukola S. Azeez, MSN, APRN, FNP-BC Michael R. Spano, MS, LAc

| 1:15 Closing Remarks/ Evaluations

| 1:30 pm Adjourn

Sherry Adkins, RN, MSN, ANP-CAdvanced Practice

Provider Supervisor

Lymphoma/Myeloma

Research

Jaime Anderson, PharmDClinical Pharmacy

Specialist

Pharmacy Clinical

Programs

Banu K. Arun, MDProfessor


Bukola S. Azeez, MSN, APRN, FNP-BCAdvanced Practice

Registered Nurse

Integrative Medicine

Program

Virginia Bayer, BSN, RN, OCNResearch Nurse

Supervisor



Katherine Bell, MSN, APRN, AOCNS, ACNS-BCAdvanced Practice Nurse

Head and Neck Surgery

Doyle Bosque, RN, BSNResearch Quality Nurse

Specialist

Chair - Clinical Research

Nurse Committee (CRNC)

Nursing Administration

Alita A.J. Campbell, MSN, RN, OCNNurse Manager

Post Anesthesia Care Unit

Janine S. Douglas, PharmD, BCPSDrug Information Clinical

Specialist

Pharmacy Medication

Management & Analytics

Danya Garner, MSN, RN-BC, OCN, CCRNNurse Educator

Nursing Education

Sandra Horowitz, PharmDClinical Pharmacy

Specialist

Pharmacy Clinical

Programs

Brittany C. Kruse, DBH, MA, BAProject Consultant

Institute for Cancer Care

Innovation

Nicole Luckett, MSN, RN, CBCNNurse Navigator

MD Anderson Cancer

Center - The Woodlands

Amanda Polk, MS, RN, OCNQuality Management

Analyst

MD Anderson Physicians

Network

Anishia Rawther-Karedath, MS, RN, AGNP-BCAdvanced Practice Nurse


Oncology

Donika Saporito, MS, CGCGenetic Counselor

Clinical Cancer Genetics

Michael R. Spano, MS, LAcAcupuncturist

Integrative Medicine

Center

Laurie Sturdevant, BA, RN, CPHQ, OCNExecutive Director

Quality Programs


Network

Richard L. Theriault, DO, MBAMedical Director


Network

Mara Villanueva, PharmD, BCPSDrug Information Clinical

Specialist

Pharmacy Medication

Management & Analytics

MD Anderson FacultyNursing Excellence:

Navigating The Changing Landscape of Oncology Nursing

Guest Faculty

Sharon Gentry, RN, MSN, ONN-CG, AOCN, CBCN Breast Nurse NavigatorNovant Health Derrick L Davis Cancer Center Winston-Salem, North Carolina

Holly N. Ho-Chee DupontPatient NavigatorThe Queen’s Medical CenterHonolulu, Hawaii

Colleen Sullivan-Moore, RN, MSLead Nurse NavigatorPresbyterian Cancer CenterAlbuquerque, New Mexico

Holly Patton, RN, BSNGynecologic Nurse NavigatorCentura HealthPueblo, Colorado

Joyce Tokuhara, RN, BSNClinical CoordinatorOncology Services & ProgramsThe Queen’s Medical CenterHonolulu, Hawaii

Ann Werle, RN, BSN, ONN-CG(T)Thoracic Nurse Navigator Covenant HealthCareSaginaw, Michigan

Registration Information

On-site registration opens at 6:30 am on Saturday, October 12, 2019. The opening

session of the symposium will begin at 7:00 am and the opening session of Nursing

Excellence will begin at 7:15 am.

Advanced registration is encouraged as space and materials are limited. Please see

registration form for applicable fees.

The deadline for advanced registration is Friday, September 20, 2019.

Please visit www.mdanderson.org/conferences to register.

A receipt and confirmation letter will be sent to you within ten working days of

receipt of your fee.

The full conference registration fee includes tuition, continental breakfasts, breaks,

lunches, and welcome reception.

Refund / Cancellation Policy

The registration fee, minus a $50 administrative handling fee, is refundable if a written

request is received on or before September 20, 2019. No refunds will be granted after

that date. The request for a registration refund must include the tax identification

number of the company or institution if registration was paid by a company or

institution check.

CME/Conference Management reserves the right to cancel activities prior to the

scheduled date, if low enrollment or other circumstances make it necessary. Each

registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the

registration form.

In case of activity cancellation, liability of CME/Conference Management

is limited to the registration fee. CME/Conference Management will refund

the full registration fee. CME/Conference Management reserves the right to

limit the number of participants in a program and is not responsible for any

expenses incurred by an individual whose registration is not confirmed and

for whom space is not available.

For additional information, contact CME/Conference Management at

713-792-2223 or toll free at 866-849-5866.

Special Assistance

Contact CME/Conference Management at 713-792-2223 or toll free at

866-849-5866 if you have any special dietary or ADA accommodation needs.

Accommodations

• A block of rooms has been reserved for symposium attendees at

Marriott Marquis Houston, 1777 Walker Street, Houston, Texas.

• Early hotel reservation is suggested.

• The hotel phone number is 713-654-1777

• When you make reservations be sure to mention the MD Anderson Cancer

Network Symposium to be assured of receiving the special meeting rate of

$249.00/night. Please add 17% Texas state and local taxes.

• Reservations and deposits received after September 12, 2019 will be confirmed

if space is available and at current hotel published guest room rates.

Ground Transportation

(prices are subject to change and variable depending on location of conference)

• Houston is served by two airports, George Bush Intercontinental

(IAH) and William P. Hobby (HOU). The following forms of ground

transportation are available to and from both airports:

• Uber or Lyft

• Yellow Cab- 713.236.1111

• Super Shuttle: For more information, call toll free at 800.258.3826

or visit www.supershuttle.com

Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chair for consideration.

CO

NFE

REN

CE

REG

ISTR

ATI

ON

- 17

6700

/30/

1213

35/4

1Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r an

d M

D An

ders

on C

ance

r Net

wor

k Sy

mpo

sium

Clin

ical

Pro

gram

: A M

ultid

isci

plin

ary

Appr

oach

to In

divi

dual

ized

Pat

ient

Car

eN

ursi

ng E

xcel

lenc

e: N

avig

atin

g th

e Ch

angi

ng L

ands

cape

of O

ncol

ogy

Nur

sing

Oct

ober

12-

13, 2

019

THIS

IS N

OT A

SEL

F-M

AILE

R - A

ddre

ss to

: Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r an

d M

D An

ders

on C

ance

r Net

wor

k Sy

mpo

sium

Depa

rtmen

t of C

ME/

Conf

eren

ce M

anag

emen

t – U

nit 1

781

The

Unive

rsity

of T

exas

MD

Ande

rson

Can

cer C

ente

r PO

Box

301

407,

Hou

ston

, TX

7723

0-14

07or

fax t

o 71

3-79

4-17

24

Mak

e ch

eck o

r mon

ey o

rder

pay

able

to:

The

Univ

ersi

ty o

f Tex

as M

D An

ders

on C

ance

r Cen

ter

Clin

ical

Pro

gram

Phys

icia

ns (M

Ds/P

hDs/

DOs)

P

ostm

arke

d be

fore

Sep

tem

ber 2

0 .

. . . .

. .$6

00P

ostm

arke

d af

ter S

epte

mbe

r 20

. . . .

. . . .

. .$6

25

MD

And

erso

n A

lum

ni /

Canc

er N

etw

ork

Phys

icia

nsP

ostm

arke

d be

fore

Sep

tem

ber 2

0 .

. . . .

. .$4

50P

ostm

arke

d af

ter S

epte

mbe

r 20

. . .

. . . .

.$47

5

Fello

ws,

Phy

sici

an A

ssis

tant

s, N

urse

s, R

esid

ents

P

ostm

arke

d be

fore

Sep

tem

ber 2

0 .

. . . .

. .$3

75P

ostm

arke

d af

ter S

epte

mbe

r 20

. . .

. . . .

.$40

0

Nur

sing

Exc

elle

nce

P

ostm

arke

d be

fore

Sep

tem

ber 2

0 .

. . . .

. .$4

25P

ostm

arke

d af

ter S

epte

mbe

r 20

. . . .

. . . .

. .$4

50

MD

Ande

rson

Par

tner

and

Phy

sici

ans

Net

wor

k N

urse

sP

ostm

arke

d be

fore

Sep

tem

ber 2

0 .

. . . .

. .$3

25P

ostm

arke

d af

ter S

epte

mbe

r 20

. . .

. . . .

.$35

0

Will

you

be

atte

ndin

g th

e Sa

turd

ay e

veni

ng re

cept

ion?

Yes

OR

N

o

Wou

ld y

ou b

e in

tere

sted

in a

tour

of M

D An

ders

on

on F

riday

, Oct

ober

11t

h?

Yes

OR

N

o

Last

Nam

eFi

rst

MI

High

est D

egre

e

Depa

rtmen

t (in

clud

e un

it no

.)

Spec

ialty

Inst

itutio

n

MD

Ande

rson

Em

ploy

ee ID

No.

(req

uire

d fo

r all

MDA

CC e

mpl

oyee

s):

Phys

icia

n Y

es

No

Stre

et

City

Stat

e/Fo

reig

n Co

untry

/Zip

or M

ail C

ode

Dayt

ime

Phon

e (w

ith a

rea

code

) Ce

ll Ph

one

(with

are

a co

de)

Fax

(with

are

a co

de)

E-m

ail A

ddre

ss (

plea

se p

rint)

Emer

genc

y Co

ntac

tPh

one

(with

are

a co

de)

Cred

it Ca

rd H

olde

r Nam

e (F

irst/

Last

) Ch

arge

the

follo

win

g: V

ISA

M

C

AM

EX

Cred

it Ca

rd N

umbe

rEx

pira

tion

Date

Secu

rity

Code

/CVV

/CSV

Cred

it Ca

rd H

olde

r Bill

ing

Addr

ess

& Z

IP C

ode

MD

And

erso

n In

terd

epar

tmen

tal T

rans

fer (

IDT)

No .

: *F

und

Grou

p 90

will

not

be

acce

pted

Bus

ines

s U

nit

D

epar

tmen

tFu

nd G

roup

*Fu

ndFu

nd T

ype

Aut

hori

zed

Sign

atur

e RE

QU

IRED

for C

RED

IT C

ARD

or I

DT

IDT

Appr

over

Nam

e (F

irst/L

ast)

plea

se p

rint

Depa

rtmen

t of C

ME/

Conf

eren

ce M

anag

emen

t- Un

it 17

81Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r17

6700

/30/

1213

35/4

1PO

Box

301

407

Hous

ton,

TX

7723

0-14

07

Non

-Pro

fit O

rg.

U.S.

Pos

tage

P A

I DHo

usto

n, T

XPe

rmit

No.

705

2

Documents

The University of Texas MD Anderson Cancer Center and MD … · 2020-06-15 · • Understand molecular biology and immunology of brain metastases to utilize the most effective systemic